1.
Patents on Risk Evaluation and Mitigation Strategies for Prescription Drugs and Generic Competition.
JAMA
; 331(11): 976-978, 2024 03 19.
Artículo
en Inglés
| MEDLINE
| ID: mdl-38386345
RESUMEN
This cross-sectional study identifies the prevalence of patents on risk evaluation and mitigation strategies and their association with delaying generic competition.